News-Papers
Testimonial
Video Gallery
Melatonin and its contribution to tumor attenuation in systemic malignancies
Published on Thursday, 14 August 2014
Letter To The Editor
See also About Melatonin.
Search
Follow us...
Latest
- Somatostatin in oncology, the overlooked evidences
- Molecular mechanisms of melatonin anticancer effects
- Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)
- Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer
- Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases
- Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study
- Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect
- Melatonin as a modulator of apoptosis in B-Lymphoma Cells
- Cancer and Vitamin E
- About melatonin - 1996
- Vitamin D and cancer
- All-trans-retinoic acid and cancer
- Modulation of Radiation-induced Base Excision Repair Pathway Gene Expression by Melatonin
- Melatonin, circadian rhythms and breast cancer
- Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts
- THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
- Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer